This allows you to focus on your treatment objectives
Ready to lose weight on authentic Compounded tirzepatide
For weight loss, semaglutide (Wegovy), a glucagon-like peptide-1 (GLP-1) receptor agonist, and tirzepatide (Zepbound), a glucose-dependent insulinotropic polypeptide receptor and GLP-1 receptor agonist, are now FDA approved for treatment of obesity and actively being evaluated for treatment of MASLD/MASH (79, 80)
Silva will consider your medical history, goals, previous GLP-1 experience, side effects, treatment response, and budget before recommending a treatment plan
Both medications carry a black box warning for this